Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

Acute treatments are used to provide headache relief during a migraine episode ... interviewed by GlobalData had noted that the gepants had similar efficacy to the triptans and as such, favourable ...

Menstrual migraine affects more than half of people with both periods and migraine. Find out what you can do to manage this ...

A coverage with evidence development (CED) study demonstrated significant and clinically meaningful benefits in patients with migraine treated with remote electrical neuromodulation (REN). Health ...

Migraine is a disabling condition ... and less need for rescue medication compared with acetaminophen, gepants, NSAIDs, and triptan monotherapy. The Clinical Guidelines Committee, led by the ...

Appropriate acute medications for symptom relief during migraine attacks, potentially including newer options like gepants or ditans for those who cannot take or don’t respond to traditional ...

The drug is approved both to treat and prevent migraine in adults and is one of ... there is fierce competition with several oral CGRP drugs or 'gepants' on the market including AbbVie's Ubrelvy ...

Ubrelvy tablets are prescribed to treat migraine episodes in adults ... receptor antagonists (or gepants). Nurtec ODT and Qulipta aren’t known to specifically interact with Ubrelvy.

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

Vyepti was approved by the FDA for the prevention of migraine in adults in 2020. As the last of the anti-CGRP mAbs to enter the migraine market, Vyepti has seen moderate uptake since its approval ...